Form 4: Boston Scientific EVP Wendy Carruthers Executes Stock Options and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
EVP of Human Resources at Boston Scientific, Wendy Carruthers, exercised stock options and sold shares of common stock under a pre-established Rule 10b5-1 trading plan.
Summary
- Wendy Carruthers, EVP of Human Resources at Boston Scientific, executed transactions involving Boston Scientific common stock on June 3, 2024.
- Carruthers exercised stock options to acquire 3,066 shares at $17.26 and 1,197 shares at $24.55.
- She then sold 6,983 shares at $75.33.
- These transactions were conducted under a pre-established Rule 10b5-1 trading plan adopted on November 17, 2023.
- Following these transactions, Carruthers directly owns 45,628 shares of Boston Scientific common stock and holds options to purchase 38,761 additional shares.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The use of a 10b5-1 plan indicates that the insider's trading activity was pre-planned and not based on any material non-public information.
Comparison to Industry Standards
- Monitoring insider transactions is a standard practice in corporate governance.
- Companies like Medtronic (MDT) and Abbott Laboratories (ABT) also have executives who regularly file Form 4s.
- The use of Rule 10b5-1 plans is common among executives to avoid accusations of insider trading.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the sale of shares by an executive.
- The filing provides transparency to stakeholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 2017-02-22 | First anniversary of stock option grant vesting in four equal annual installments. |
| 2018-02-28 | First anniversary of stock option grant vesting in four equal annual installments. |
| 2023-11-17 | Date of adoption of the Rule 10b5-1 trading plan. |
| 2024-06-03 | Date of the reported transactions (exercise of options and sale of shares). |
| 2026-02-22 | Expiration date of stock options. |
| 2027-02-28 | Expiration date of stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.